Inhibition of the myotoxic activity of Bothrops asper myotoxin II in mice by immunization with its synthetic 13-mer peptide 115-129

Toxicon

Volumn 37, Issue 4, 1999, Pages 683-687

  Calderón, Leonel ^a   Lomonte, Bruno ^a  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; ANTIGEN; CREATINE KINASE; DIPHTHERIA TOXOID; DRUG CARRIER; HEPARIN; PHOSPHOLIPASE A2; SNAKE VENOM; SYNTHETIC PEPTIDE; TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; BINDING SITE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CROSS REACTION; ENZYME IMMUNOASSAY; IMMUNIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; MUSCLE; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; TOXICITY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BOTHROPS; CREATINE KINASE; CROSS REACTIONS; DIPHTHERIA TOXOID; EPITOPES, B-LYMPHOCYTE; IMMUNIZATION; IMMUNODOMINANT EPITOPES; IMMUNOENZYME TECHNIQUES; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; NECROSIS; PEPTIDE FRAGMENTS; PHOSPHOLIPASES A; SNAKE VENOMS;

ANIMALIA; BOTHROPS ASPER; INVERTEBRATA; SERPENTES;

EID: 0032969823     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(98)00211-6     Document Type: Article

References (14)

1. Arni R.K., Ward R.J., Gutiérrez J.M., Tulinsky A. Structure of a calcium-independent phospholipase-like myotoxic protein from Bothrops asper venom. Acta Cryst. D. 51:1995;311-317.
2. 2 from Bothrops asper snake venom. Arch. Biochem. Biophys. 358 (in press).
3. 2 reduces its membrane-destabilizing effect. Arch. Biochem. Biophys. 312:1994;336-339.
4. 2 Enzymes: Structure, Function, and Mechanism. John Wiley and Sons, England, pp. 455-497.
5. 2. Arch. Biochem. Biophys. 284:1991;352-359.
6. 2 Enzymes: Structure, Function, and Mechanism. John Wiley and Sons, England, pp. 321-352.
7. Lomonte B., Gutiérrez J.M. A new muscle damaging toxin, myotoxin II, from the venom of the snake Bothrops asper (terciopelo). Toxicon. 27:1989;725-733.
8. Lomonte B., Kahan L. Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin. Toxicon. 26:1988;675-689.
9. Lomonte B., Gutiérrez J.M., Carmona E., Rovira M.E. Equine antibodies to Bothrops asper myotoxin II: isolation from polyvalent antivenom and neutralizing ability. Toxicon. 28:1990;379-384.
10. 2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling. J. Biol. Chem. 269:1994;29867-29873.
11. 2 from Bothrops asper snake venom by glycosaminoglycans of the heparin/heparan sulfate family. Biochem. Pharmacol. 47:1994;1509-1518.
12. 2 from Bothrops asper snake venom: synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur. J. Biochem., in press.
13. 2 from bovine pancreas and Crotalus atrox venom. J. Biol. Chem. 260:1985;11627-11634.
14. Rucavado A., Lomonte B. Neutralization of myonecrosis, hemorrhage, and edema induced by Bothrops asper snake venom by homologous and heterologous pre-existing antibodies in mice. Toxicon. 34:1996;567-577.